Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB.

ERBB family TCGA bioinformatics estrogen-dependent cancer female-specific cancers machine learning microRNAs

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
02 Jun 2022
Historique:
received: 14 04 2022
revised: 25 05 2022
accepted: 29 05 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Big data processing, using omics data integration and machine learning (ML) methods, drive efforts to discover diagnostic and prognostic biomarkers for clinical decision making. Previously, we used the TCGA database for gene expression profiling of breast, ovary, and endometrial cancers, and identified a top-scoring network centered on the

Identifiants

pubmed: 35740327
pii: biomedicines10061306
doi: 10.3390/biomedicines10061306
pmc: PMC9219956
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D1013-D1017
pubmed: 30364956
Front Chem. 2020 Jul 31;8:600
pubmed: 32850635
Front Genet. 2020 Dec 03;11:612521
pubmed: 33424936
PLoS One. 2018 Jan 30;13(1):e0191972
pubmed: 29381731
Oncol Rep. 2019 Jun;41(6):3233-3243
pubmed: 31002358
BMC Genomics. 2016 Dec 22;17(Suppl 13):1025
pubmed: 28155657
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Mol Med Rep. 2020 Jan;21(1):347-359
pubmed: 31939629
Front Oncol. 2020 Jul 21;10:1084
pubmed: 32850313
Breast Cancer Res. 2013 Apr 19;15(2):R33
pubmed: 23601657
BMC Genomics. 2016 Aug 22;17 Suppl 7:525
pubmed: 27556158
Mol Oncol. 2014 Feb;8(1):93-104
pubmed: 24148764
Oncol Rep. 2016 Feb;35(2):1075-82
pubmed: 26718987
Cancer Lett. 2020 Jan 28;469:54-67
pubmed: 31629932
Indian J Dent Res. 2017 Nov-Dec;28(6):687-694
pubmed: 29256471
Clin Obstet Gynecol. 2016 Dec;59(4):688-709
pubmed: 27741212
Front Genet. 2019 Aug 20;10:743
pubmed: 31481972
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Int J Clin Exp Pathol. 2015 Jun 01;8(6):6143-56
pubmed: 26261492
Int J Mol Sci. 2020 Dec 24;22(1):
pubmed: 33374439
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302
pubmed: 29126174
Cancers (Basel). 2019 Mar 26;11(3):
pubmed: 30917548
Genes (Basel). 2019 Jan 23;10(2):
pubmed: 30678090
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
BMC Bioinformatics. 2019 Sep 18;20(1):480
pubmed: 31533612
Cancer Biomark. 2020;27(2):225-242
pubmed: 32083575
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Saudi Pharm J. 2021 May;29(5):446-455
pubmed: 34135670
J Transl Med. 2019 Aug 8;17(1):260
pubmed: 31395072
Cancers (Basel). 2021 Jul 06;13(14):
pubmed: 34298609
Nat Commun. 2013;4:2126
pubmed: 23839242
Front Med (Lausanne). 2021 Mar 09;8:635771
pubmed: 33768105
Cancer Cell Int. 2017 Oct 24;17:95
pubmed: 29089858
Oncotarget. 2016 Apr 12;7(15):19519-30
pubmed: 26799586
Endocrine. 2021 Jun;72(3):758-783
pubmed: 33179221
Cancers (Basel). 2019 Jun 27;11(7):
pubmed: 31252695
BMC Syst Biol. 2019 Mar 20;13(1):33
pubmed: 30894171
J Med Internet Res. 2021 Apr 1;23(4):e22394
pubmed: 33792552
Front Oncol. 2021 Aug 26;11:627811
pubmed: 34513655
World J Surg Oncol. 2021 Aug 6;19(1):230
pubmed: 34362391
Sci Adv. 2020 Jul 1;6(27):
pubmed: 32937430
Clin Biochem. 2018 Sep;60:24-32
pubmed: 30063890
Brief Bioinform. 2021 Mar 22;22(2):1984-1999
pubmed: 32103253
Nat Commun. 2018 Oct 17;9(1):4319
pubmed: 30333487
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Endocrine. 2019 Sep;65(3):582-594
pubmed: 30927143
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Thorac Cancer. 2021 Sep;12(18):2427-2438
pubmed: 34324278
Cancer Cell. 2018 Apr 9;33(4):690-705.e9
pubmed: 29622464
Cancer Cell. 2006 Dec;10(6):515-27
pubmed: 17157791
Cancer Gene Ther. 2021 May;28(5):413-426
pubmed: 32948832
Theranostics. 2021 Mar 11;11(11):5330-5345
pubmed: 33859750
J Biol Chem. 2009 Sep 11;284(37):24696-704
pubmed: 19584056
Breast Cancer. 2018 Nov;25(6):742-752
pubmed: 29951881
Int J Mol Sci. 2022 Jan 30;23(3):
pubmed: 35163534
Cell Cycle. 2021 Jul;20(13):1295-1307
pubmed: 34125645
Sci Rep. 2020 Sep 2;10(1):14452
pubmed: 32879391
Mol Med Rep. 2020 Nov;22(5):4048-4060
pubmed: 33000259
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
Curr Opin Obstet Gynecol. 2020 Feb;32(1):57-64
pubmed: 31833974
Mol Cancer. 2014 Apr 28;13:92
pubmed: 24775712
Front Genet. 2021 Nov 25;12:724785
pubmed: 34899827
Dig Dis Interv. 2020 Mar;4(1):73-81
pubmed: 32869010
Crit Rev Oncol Hematol. 2021 Jan;157:103174
pubmed: 33249359
Cancer Inform. 2019 Feb 13;18:1176935119828746
pubmed: 30792572

Auteurs

Katia Pane (K)

IRCCS Synlab SDN, 80143 Naples, Italy.

Mario Zanfardino (M)

IRCCS Synlab SDN, 80143 Naples, Italy.

Anna Maria Grimaldi (AM)

IRCCS Synlab SDN, 80143 Naples, Italy.

Gustavo Baldassarre (G)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy.

Marco Salvatore (M)

IRCCS Synlab SDN, 80143 Naples, Italy.

Mariarosaria Incoronato (M)

IRCCS Synlab SDN, 80143 Naples, Italy.

Monica Franzese (M)

IRCCS Synlab SDN, 80143 Naples, Italy.

Classifications MeSH